180 Life Sciences Corp. is a biotech company focusing on developing drugs for inflammatory diseases, fibrosis, and pain. Founded in 2016, it collaborates with experts from Oxford, Hebrew, and Stanford Universities, aiming to address unmet medical needs. Based in Palo Alto, CA.